Roger Day

6.6k total citations · 3 hit papers
70 papers, 4.8k citations indexed

About

Roger Day is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Roger Day has authored 70 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 20 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Roger Day's work include Cancer Genomics and Diagnostics (7 papers), Genetics, Bioinformatics, and Biomedical Research (6 papers) and Statistical Methods in Clinical Trials (5 papers). Roger Day is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Genetics, Bioinformatics, and Biomedical Research (6 papers) and Statistical Methods in Clinical Trials (5 papers). Roger Day collaborates with scholars based in United States, United Kingdom and Canada. Roger Day's co-authors include Douglas B. Fridsma, Heather Piwowar, John Bryant, Theresa L. Whiteside, William E. Gooding, Marilyn M. Wagener, Jennifer R. Grandis, Mona F. Melhem, Valerie A. Holst and Stephanie D. Drenning and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Roger Day

69 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival

1998 913 citations William E. Gooding, Roger Day et al. profile →
Sharing Detailed Research Data Is Associated with Increased Citation Rate

2007 547 citations Heather Piwowar, Roger Day et al. PLoS ONE profile →
Invasiveness, biology, ecology, and management of the fall armyworm, Spodoptera frugiperda

2022 222 citations Roger Day et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger Day United States	31	1.7k	1.6k	732	647	486	70	4.8k
Ning Lü China	41	1.5k 0.9×	1.3k 0.8×	1.3k 1.8×	973 1.5×	689 1.4×	244	6.1k
Patricia Rockwell United States	33	1.8k 1.1×	2.5k 1.6×	714 1.0×	603 0.9×	806 1.7×	69	5.4k
Wendy Liu United States	35	1.6k 0.9×	2.2k 1.4×	658 0.9×	375 0.6×	318 0.7×	101	5.8k
Lu Zhang China	42	1.1k 0.7×	1.2k 0.8×	752 1.0×	1.6k 2.5×	541 1.1×	207	10.1k
TL Lee Hong Kong	42	635 0.4×	2.7k 1.7×	432 0.6×	567 0.9×	1.0k 2.1×	136	5.3k
Hao Chen China	38	831 0.5×	1.9k 1.2×	635 0.9×	1.1k 1.6×	504 1.0×	324	5.7k
Eivind Hovig Norway	46	2.2k 1.3×	6.0k 3.7×	781 1.1×	685 1.1×	2.3k 4.7×	218	8.9k
Bethany L. Wagner United States	28	1.0k 0.6×	1.0k 0.6×	664 0.9×	241 0.4×	409 0.8×	66	3.9k
Linda K. Green United States	40	922 0.6×	774 0.5×	1.8k 2.4×	514 0.8×	364 0.7×	173	6.1k
Eva C. Guinan United States	39	1.0k 0.6×	1.3k 0.8×	516 0.7×	1.5k 2.3×	417 0.9×	135	6.4k

Countries citing papers authored by Roger Day

Since Specialization

Citations

This map shows the geographic impact of Roger Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Day more than expected).

Fields of papers citing papers by Roger Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Day. The network helps show where Roger Day may publish in the future.

Co-authorship network of co-authors of Roger Day

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Day. A scholar is included among the top collaborators of Roger Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Day. Roger Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Day, Roger. (2016). Planning clinically relevant biomarker validation studies using the “number needed to treat” concept. Journal of Translational Medicine. 14(1). 117–117. 2 indexed citations

Rodriguez, Gustavo C., H. John Barnes, Kenneth E. Anderson, et al.. (2013). Evidence of a Chemopreventive Effect of Progestin Unrelated to Ovulation on Reproductive Tract Cancers in the Egg-laying Hen. Cancer Prevention Research. 6(12). 1283–1292. 13 indexed citations

Risinger, John I., Uma Chandran, Roger Day, et al.. (2013). Gene Expression Analysis of Early Stage Endometrial Cancers Reveals Unique Transcripts Associated with Grade and Histology but Not Depth of Invasion. Frontiers in Oncology. 3. 139–139. 30 indexed citations

Zeng, Xuemei, Brian L. Hood, Ting C. Zhao, et al.. (2011). Lung Cancer Serum Biomarker Discovery Using Label-Free Liquid Chromatography-Tandem Mass Spectrometry. Journal of Thoracic Oncology. 6(4). 725–734. 28 indexed citations

Piwowar, Heather, Roger Day, & Douglas B. Fridsma. (2007). Sharing Detailed Research Data Is Associated with Increased Citation Rate. PLoS ONE. 2(3). e308–e308. 547 indexed citations breakdown →

Ramanathan, Ramesh K., Jimmy J. Hwang, William C. Zamboni, et al.. (2004). Low Overexpression of HER-2/Neu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin®) and Irinotecan as Therapy. A Phase II Trial. Cancer Investigation. 22(6). 858–865. 118 indexed citations

Day, Roger, Adam Brufsky, Joseph Baar, et al.. (2004). Evaluation of the OncoTCap(Oncology Thinking Cap) Simulation in Teaching Medical Students About Clinical Trials: Some Successes and Some Surprises. Journal of Cancer Education. 19(3). 149–155. 1 indexed citations

Hmelo, Cindy E., Sailesh Ramakrishnan, Roger Day, et al.. (2001). Oncology Thinking Cap: Scaffolded Use of a Simulation to Learn Clinical Trial Design. Teaching and Learning in Medicine. 13(3). 183–191. 10 indexed citations

Konety, Badrinath R., Rajiv Dhir, Roger Day, et al.. (2000). Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.. PubMed. 6(7). 2618–25. 98 indexed citations

10.

Joe, Bonnie N., Melanie B. Fukui, Carolyn C. Meltzer, et al.. (1999). Brain Tumor Volume Measurement: Comparison of Manual and Semiautomated Methods. Radiology. 212(3). 811–816. 88 indexed citations

11.

Adedoyin, Adedayo, Dwight D. Stiff, David C. Smith, et al.. (1997). All- trans -retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes. Cancer Chemotherapy and Pharmacology. 41(2). 133–139. 24 indexed citations

12.

Getzenberg, Robert H., Badrinath R. Konety, Ajay K. Nangia, et al.. (1997). Vitamin d inhibition of prostate adenocarcinoma growth and metastasis in the dunning rat prostate model system. Urology. 50(6). 999–1006. 178 indexed citations

13.

Osborn, Jennifer L., Gary G. Schwartz, David C. Smith, et al.. (1995). Phase II trial of oral 1,25-dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer. Urologic Oncology Seminars and Original Investigations. 1(5). 195–198. 138 indexed citations

14.

Rubin, Joshua T., Michael T. Lotze, R. E. Howells, et al.. (1995). Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: Interim results of a phase I trial. Annals of Surgical Oncology. 2(4). 351–359. 2 indexed citations

15.

Larson, Richard A., Roger Day, N. Azarnia, et al.. (1992). The selective use of AMSA following high‐dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study. British Journal of Haematology. 82(2). 337–346. 13 indexed citations

16.

Bryant, John, Roger Day, Theresa L. Whiteside, & Ronald B. Herberman. (1992). Calculation of lytic units for the expression of cell-mediated cytotoxicity. Journal of Immunological Methods. 146(1). 91–103. 205 indexed citations

17.

Marsh, Gary M. & Roger Day. (1991). A model standardized risk assessment protocol for use with hazardous waste sites.. Environmental Health Perspectives. 90. 199–208. 11 indexed citations

18.

Larson, Richard A., Azra Raza, George P. Browman, et al.. (1991). The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure. British Journal of Haematology. 79(3). 390–397. 21 indexed citations

19.

Vlock, Daniel R., Jonas T. Johnson, Eugene Myers, et al.. (1991). Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck. Head & Neck. 13(1). 15–21. 35 indexed citations

20.

Yin, Xiaoying, M Donovan-Peluso, Theresa L. Whiteside, et al.. (1991). Gene Amplification and Gene Dosage in Cell Lines Derived From Squamous Cell Carcinoma of the Head and Neck. Genes Chromosomes and Cancer. 3(6). 443–454. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact